Randomised trial on combined effects of dual blockade of the renin angiotensin system and phosphate binding in diabetic and non-diabetic patients with impaired renal function.
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Enalapril (Primary) ; Irbesartan (Primary) ; Lanthanum carbonate (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms DUAL study
Most Recent Events
- 03 Aug 2017 New trial record